| Net Cash Provided by (Used in) Operating Activities |
$89,262 |
USD |
|
Q3 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$192,062 |
USD |
|
Q3 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q3 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
5,000,000,000 |
shares |
0% |
Q1 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
2,095,671,162 |
shares |
0% |
Q1 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$281,324 |
USD |
25545% |
Q3 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$1,003 |
USD |
|
Q1 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$0 |
USD |
-100% |
Q2 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$1,168,338 |
USD |
-1109% |
Q1 2025 |
Q3 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q1 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
20,000,000 |
shares |
0% |
Q1 2025 |
Q3 2025 |
| Additional Paid in Capital |
$3,640,360 |
USD |
-450% |
Q1 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
-100% |
Q2 2024 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2025 |
Q3 2025 |